The response of the left ventricle to a level of supine bicycle exercise that induced angina, and the effects of ouabain (0.01 mg/kg) on this response were evaluated in 14 patients with coronary arterial disease. Before administration of ouabain, exercise was associated with depressed pumping performance of the left ventricle in four patients: stroke work fell with exercise while left ventricular end-diastolic pressure (LVEDP) increased. In five patients left ventricular (LV) performance was not frankly depressed, but nevertheless was abnormal: stroke work increased, but was accompanied by an inordinately large rise in LVEDP. In the remaining five patients LV function was essentially normal. Ouabain improved LV performance at rest in only a minority of patients, but during the stress of exercise, LV hemodynamics were improved by ouabain in 12 of the 14 patients. Five patients, however, continued to show either depressed or abnormal function with exercise after they were given ouabain. As judged by the relationship of LVEDP to LV peak dp/dt, left ventricular contractility was increased by ouabain in most 
PREVIOUS investigations1-6 have demonstrated that most patients with ischemic heart disease respond to exercise with an abnormal increase in left ventricular enddiastolic pressure (LVEDP), and this has been interpreted as a manifestation of left ventricular (LV) failure.5 6 We undertook the present study to determine whether LV function invariably deteriorates when angina pectoris is induced by exercise in patients with coronary arterial disease, and whether LV hemodynamics and exercise tolerance can be favorably altered by the administration of a cardiac glycoside. In addition, we attempted to correlate the hemodynamic data with the cineangiographic appearances of the coronary arteries and left ventricle.
Methods
Thirteen men and one woman, aged 30 to 60 years (average, 46 years), were studied. All were limited by typical angina pectoris, and eight had a history of previous myocardial infarction. Three patients also had mild aortic stenosis with peak transvalvular gradients of 4, 10, and 12 mm Hg, respectively, and one of these three had mild aortic regurgitation as well. One patient was receiving methyldopa for systemic arterial hypertension and when studied was normotensive. Two patients were receiving digoxin when admitted to Stroke-volume index (ml/m2) was calculated by dividing cardiac index by heart rate, and left ventricular mean systolic ejection rate index (ml/sec/M2) by dividing stroke-volume index by systolic ejection time.7 Tension-time index (mm Hg-sec/min) was calculated8 as the product of heart rate, ejection time, and the mean left ventricular pressure during ejection (mean pressure was measured by planimetric integration), and the pressure-rate product (mm Hg/min) was calculated as the product of LV peak systolic pressure and heart rate. LV stroke-work index (LVSWI) was computed as follows:
LVSWI (g-m/m2) = (LVSP -LVEDP) x SVI x 0.136 where LVSP represents the mean LV pressure during ejection and SVI, the stroke-volume index. The maximal rate of rise of the left ventricular pressure pulse (LV peak dp/dt in mm Hg/sec) was measured directly from pressure tracings recorded at a paper speed of 200 mm/sec. Although dp/dt is measured most 1 ). When LVEDP did increase, the rise usually began with the onset of exercise and continued throughout the exercise period; an additional increase in LVEDP at the onset of angina was unusual. There was no correlation between the level of LVEDP at rest and the magnitude of its rise with exercise.
After Administration of Ouabain LVEDP averaged 10.9 mm Hg (range, [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] when the patients were resting in the supine position, and was above 12 mm Hg in four of them. LVEDP again rose in every patient when the legs were elevated (average LVEDP, 15.6; range, 9-23 mm Hg). A further significant increase occurred with exercise (average LVEDP, 20.4; range, 9-40 mm Hg). In eight patients, however, LVEDP either remained the same during exercise or increased less than 3 mm Hg. In one additional patient LVEDP fell during exercise. +30r-A. Efects of passive elevation of the legs on left ventricular hemodynamics before ouabain was given. Change in LVEDP is related to the changes that occurred in stroke-volume index (SVI), stroke-work index (SWI), and LV peak dp/dt when the patients' legs were raised onto the pedals of the bicycle ergometer. The same numbers are used to identify individual patients in the subsequent figures.
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When end-diastolic pressures before and after ouabain was administered were compared, no significant differences were found at rest. During exercise, however, LVEDP was significantly lower after ouabain was given (table 1) .
Cardiac Output, Stroke Volume, and Stroke Work Cardiac output increased with exercise both before and after ouabain was given (table 1) . The increase in output was roughly proportional to the increase in heart rate, and thus stroke volume did not change significantly. LV stroke work did not change with exercise before ouabain was administered, but increased (P < 0.05) with exercise after the glycoside was given. Ouabain did not significantly alter cardiac output, stroke volume, or stroke work at rest, but during exercise each of these indices was significantly (P <0.01) higher after the drug was given. Although stroke volume was essentially unchanged by exercise, systolic ejection period decreased, and, therefore, mean systolic ejection rate increased with exercise both before (average increase 11%; P < 0.025) and after (average increase 15%; P < 0.01) ouabain was given. Ouabain increased the average systolic ejection rate (table 1) both at rest (by 10%) and during exercise (by 14%), but only the latter change was significant (P < 0.01).
LV Peak dp/dt Dp/ dt increased (P < 0.01) with exercise in each patient both before and after administration of ouabain. Moreover, ouabain caused a significant (P < 0.05) increase in dp/dt at rest and during exercise. Thus, exercise and ouabain each caused an increase in dp/dt, and the effects of the two interventions on dp/dt were additive. Pressures, cardiac output, and dp/dt were measured in ten patients in the supine position and again after their feet were raised onto the pedals of the bicycle ergometer, an intervention that would be expected to increase filling of the left ventricle without changing its contractile state. Raising the legs uniformly resulted in a rise in LVEDP, and in most patients this was accompanied by a rise in stroke volume, stroke work, and dp/dt ( fig.  2) . Although in an occasional patient the increase in LVEDP was accompanied by a fall in either stroke volume, stroke work, or dp/dt, in no patient did all three of these indices fall.
In all 14 In the majority of patients ouabain did not improve the performance of the left ventricle as a pump during resting conditions ( fig. 5 ). In contrast, the pumping characteristics of the left ventricle were improved by ouabain in 12 of 14 patients when the heart was stressed by exercise ( fig. 6 ): stroke volume and stroke work increased, while LVEDP remained the same or decreased.
Patients 2 and 14 had the largest increases in LVEDP with exercise before they were given ouabain ( fig. 3) , and in these two patients ouabain improved ventricular performance at rest ( fig. 5 ) and during exercise ( fig. 6 ). Despite this improvement, ventricular performance still deteriorated during exercise in both of them (fig. 4) . These results contrast with those obtained in patient 7, who also Figure 7 Effects of ouabain on left ventricular contractility. Both at rest (A) and during exercise (B) ouabain increased the contractility of the left ventricle in most patients: LV peak dp/dt increased while LVEDP decreased or remained the same. more. Thus, all patients had severe coronary arterial disease, but in general it was more extensive in those with abnormal left ventriculograms. Both at rest and during exercise the average LVEDP tended to be lower in the six patients with normal left ventriculograms than in the six with focal areas of hypokinesis or akinesis, but the only values which were significantly different were those obtained with the patients at rest before ouabain was given (15.2 vs. 20.5 mm Hg, P<0.05). Neither at rest nor during exercise were cardiac index, stroke volume, stroke work, systolic ejection rate, peak dp/dt, tension-time index, or pressure-rate product significantly different between the two groups; this was true both before and after ouabain was given. In addition, there was no difference in the duration of exercise that induced angina. In each of the two groups, the left ventricular response to exercise was normal in some patients but abnormal in others ( fig. 3) , and the effects of ouabain were striking in some but negligible in others ( figs. 4-7) . There was, therefore, little correlation between the angiographic appearance of the left ventricle and its response to exercise or to ouabain.
Discussion
In this as in most other hemodynamic studies of patients with coronary arterial disease,1-6 LVEDP was found to increase abnormally with exercise in the majority of patients. However, frank depression in the performance of the left ventricle as a pump (i.e., a rise in LVEDP accompanied by a fall in stroke volume and stroke work) occurred in only a minority of patients. In others, the abnormal rise in LVEDP with exercise was accompanied by an increase in LV stroke volume and/or work. Although this latter combination of changes cannot be interpreted as indicating an unequivocal depression of ventricular function, the response is not a normal one. 9 Several mechanisms could contribute to the impaired ventricular response to exercise manifest by these patients. If permanent myocardial damage caused by prior episodes of ischemia was extensive, the left ventricle might chronically be operating on the flat portion of a depressed function curve, and with exercise any increase in left ventricular end-diastolic volume would be accompanied by only a small rise, no change, or even a fall in stroke volume. Alternatively, the transient myocardial ischemia that occurs during angina, if sufficiently widespread, might depress ventricular function acutely even in the absence of permanent myocardial disease, or might exaggerate any chronic impairment of ventricular function.
Both of the above explanations are based on the assumption that the abnormal increase in LVEDP observed during exercise reflects an abnormal increase in left ventricular enddiastolic volume. It is possible, however, that the rise in LVEDP is due instead, or at least in part, to diminished ventricular compliance. If compliance were chronically decreased, a small increase in LV end-diastolic volume, which might be appropriate for the increase in stroke volume, would be accompanied by an abnormally large increase in LVEDP. A chronic change in compliance, however, can not in itself account for those situations in which a rise in LVEDP is associated with a fall in stroke volume and work. To evoke a decrease in compliance as the mechanism responsible for such a combination of changes, one would have to postulate that ischemia causes an acute reduction in left ventricular compliance so that LVEDP rises despite a lack of change, or even a reduction, in enddiastolic volume.10
As has been found in other studies,3 11 a few patients developed exertional angina in the absence of an abnormal increase in LVEDP, or of any other indication of a deterioration in LV performance. This finding is not unexpected since pain presumably can arise from an ischemic segment of myocardium sufficiently small so as to produce no detectable abnormality in the function of the ventricle as a whole. When LVEDP does increase with exercise, it usually begins to rise during the first minute of exertion and before angina appears. Other investigators also have Circulation, Volume XLII, January 1 971 found that LVEDP increases during the first minute or two of exercise in patients with coronary disease,2 3 and that some patients do not develop angina despite abnormal rises in LVEDP.2 6. 12 Thus, although exertional angina and elevation of LVEDP are often found together, either may occur in the absence of the other.
Ouabain did not significantly change stroke volume, stroke work, systolic ejection rate, or LVEDP at rest; but when the left ventricle was stressed by exercise, ouabain increased stroke volume, stroke work, and systolic ejection rate, and decreased LVEDP. When the relationship of stroke volume or stroke work to LVEDP was used for evaluation of the performance of the left ventricle as a pump, ouabain was found to improve LV performance in only a minority of patients at rest, but in almost all patients during exercise. In no patient was LV performance worse after ouabain was given. When the effects of ouabain on the performance of the heart as a muscle were considered, it was found that left ventricular peak dp/dt was significantly higher after ouabain was given, both at rest and during angina induced by exercise Although LV performance improved after administration of ouabain in most patients, exercise capacity increased in only four subjects, decreased in two, and remained unchanged in eight. Malmborg16 reported improved exercise capacity in patients with coronary arterial disease after the administration of lanatoside C, but in two more recent studies,6 17 cardiac glycosides did not influence exercise tolerance. The failure of ouabain to delay significantly the onset of angina in our patients is not surprising since the frequency and magnitude of intraventricular pressure development, two important determinants of myocardial oxygen consumption, were not appreciably altered by the drug (table 1) .
These are not, of course, the only determinants of myocardial oxygen consumption. Two others are left ventricular volume and the contractile state of the myocardium,18 and it is of interest that in each of the four patients who exercised longer after ouabain was given, LVEDP was lower while dp/dt was unchanged or diminished, whereas in both of the patients who experienced angina sooner after ouabain was given, dp/dt increased appreciably after administration of the glycoside while LVEDP did not change or increased slightly. Although these changes could explain the effects of ouabain on the exercise capacity of these patients, other patients whose exercise capacity was unchanged by ouabain had similar changes in LVEDP and dp/dt after receiving the drug. Thus, neither these nor any of the other hemodynamic parameters measured in this study could be used to predict the effect of ouabain on exercise tolerance.
In this relatively small number of patients, we found little correlation between the angiographic appearance of the left ventricle and various hemodynamic parameters of its performance. Although other investigators also have noted abnormal LV function in patients whose ventricles had a normal appearance, in general they have found the hemodynamic abnormalities to be even more severe in patients with abnormal left ventriculograms.2, 19 20 Rowe and associates could not correlate the severity of coronary arterial disease with hemodynamic measurements made with the patients at rest,21 and in the present study coronary arteriography was of no value in predicting either the patient's hemodynamic response to exercise or his exercise capacity. In addition, the response of the left ventricle to ouabain did not appear to be influenced by the extent of the coronary arterial disease or by the presence or absence of focal areas of ventricular akinesis.
In conclusion, it is clear that the hemodynamic effects of exercise and exercise-induced myocardial ischemia in patients with coronary arterial disease are not uniform; although most patients manifest an unequivocally abnormal response, other patients, under the circumstances of the present investigation, respond in a manner that is indistinguishable from that of normal subjects. In many patients with coronary arterial disease ouabain enhances left ventricular performance during exercise, but no firm conclusions can be drawn as to the relative roles of a depression in contractility and a decrease in compliance in producing the abnormal ventricular response so frequently observed during exercise. Finally, despite the beneficial hemodynamic effects produced by ouabain, the exercise capacity of patients with coronary arterial disease is not consistently improved by the administration of this drug.
